The Neurology department provides a specialist (tertiary) service for the diagnosis and treatment of children with neurological disorders, who are already under the care of a paediatrician or other paediatric specialist.
What you and your child experience when you come to Great Ormond Street Hospital (GOSH) matters to us. We want to provide the best experience possible during what we realise must be a difficult time in your lives.
Now in its fourth year, Family Arts Week took place at Great Ormond Street Hospital (GOSH) from the 23 – 27 October. During the week families enjoyed pop-up performances and workshops in unexpected places across the hospital, including in the reception, lift lobbies, the Activity Centre, the Lagoon Restaurant and on the wards!
Walk down to Level 1 of the Frontage Building, and you'll discover the National Institute for Health Research (NIHR) Great Ormond Street Clinical Research Facility (CRF). This bright and colourful purpose-built centre provides a specialist ward area for children taking part in research studies.
The Social Work service is part of the Psychosocial and Family Services at Great Ormond Street Hospital (GOSH.) The service includes social workers, family support officers and family support workers, providing a direct service to children and families.
We are firm believers that the amazing work of our staff needs to be recognised. The staff at Great Ormond Street Hospital (GOSH) produce research at many different levels ranging from excellent clinical audits to randomised control trials.
A new protein that appears to play a role in mitochondrial disease – a rare condition where a lack of energy in cells means that they can’t function properly – could prove to be important in conditions such as Alzheimer’s, Parkinson’s and Huntington’s diseases.
October 2015 saw the first ever Family Arts Week take over Great Ormond Street Hospital (GOSH). Part of the national Family Arts Festival event, the week has been run by GOSH Arts, the hospital’s arts programme, and the Activity Centre.
At the end of 2016, the American Food and Drug Administration (FDA) granted approval for the use of Spinraza (nusinsersen) for the treatment of spinal muscular atrophy (SMA) in paediatric and adult patients. This is unprecedented for the SMA community witnessing the first approved drug for this disease.
A new artificially intelligent bodysuit to help understand how mobility is affected in boys with Duchenne will be trialled in a collaboration between researchers at Great Ormond Street Hospital (GOSH) and Imperial College London.
The NIHR Great Ormond Street Biomedical Research Centre (BRC) has been awarded £37 million in funding to drive forward translational research into rare diseases in children. The Centre is the only one of its kind in the UK dedicated to paediatric research.
Researchers at Great Ormond Street Hospital (GOSH) have made an important breakthrough in understanding how the immune system becomes disrupted in Wiskott-Aldrich syndrome (WAS), a genetic disorder where the patient’s immune cells begin attacking their own body.